IDO1 and Hepatic fibrosis: Interestingly, fibrosis reduction and inhibition of IDO1 expression and STAT3 activity were observed in vitro TGF-β1-induced hepatic stellate cell model and in vivo CCl4-induced rat hepatic fibrosis model after administration of Danshensu (82).